Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling Up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali.

CONTEXT: In Mali, malaria transmission is seasonal, exposing children to high morbidity and mortality. A preventative strategy called Seasonal Malaria Chemoprevention (SMC) is being implemented, consisting of the distribution of drugs at monthly intervals for up to 4 months to children between 3 and 59 months of age during the period of the year when malaria is most prevalent. This study aimed to analyze the evolution of the incidence of malaria in the general population of the health districts of Kati, Kadiolo, Sikasso, Yorosso, and Tominian in the context of SMC implementation. METHODS: This is a transversal study analyzing the routine malaria data and meteorological data of Nasa Giovanni from 2016 to 2018. General Additive Model (GAM) analysis was performed to investigate the relationship between malaria incidence and meteorological factors. RESULTS: From 2016 to 2018, the evolution of the overall incidence in all the study districts was positively associated with the relative humidity, rainfall, and minimum temperature components. The average monthly incidence and the relative humidity varied according to the health district, and the average temperature and rainfall were similar. A decrease in incidence was observed in children under five years old in 2017 and 2018 compared to 2016. CONCLUSION: A decrease in the incidence of malaria was observed after the SMC rounds. SMC should be applied at optimal periods.

[Study on the clinical and epidemiological characteristics of the first 1030 cases of covid-19 in Mali]. / Etude sur les caracteristiques cliniques et epidemiologiques des 1030 premiers cas de covid-19 au Mali.

AIMS: Since the confirmation of the first cases of COVID-19 in Mali in March 2020 and the outbreakspreading to the whole country, clinical and epidemiological data fromaffected patients are used to characterize the disease. This study was to describe the clinica lsigns and epidemiologicalparameters of COVID-19 in the Malian context. MATERIALS AND METHODS: This is a cross-sectional study. All confirmed cases of COVID-19 in Mali between March 25, 2020 to May 24, 2020 have been included. Clinical and epidemiological data from patients with COVID-19 were extracted from the official line list of cases and the national reference laboratory register. RESULTS: The mean age of the 1,030 patients was 45.6 ± 18.4 years; 67.2% of patients were men. Asymptomatic patients accounted for 31.1%. The most common symptoms on admission were cough (60.8%) followed by fever (47.6%). The largest number of cases was recorded in Bamako. CONCLUSION: SARS-CoV-2 infection of the first 1,030 cases in Mali was marked by the predominance of cough and fever.

BUTS: Depuis la confirmation des premiers cas de COVID-19 au Mali en Mars 2020 et sa propagation à tout le pays, des données cliniques et épidémiologiques des patients atteints sont utilisées pour caractériser la maladie. Cette étude avait pour objectif d'étudier les signes cliniques et épidémiologiques de la COVID-19 dans le contexte malien. MATÉRIELS ET MÉTHODES: Il s'agit d'une étude transversale. Tous les cas confirmés de COVID-19 du Mali entre le 25 Mars 2020 au 24 Mai 2020 ont été inclus. Les données cliniques et épidémiologiques des patients atteints de COVID-19ont été extraites. RÉSULTATS: L'âge moyen descas était de 45,6±18,4 ans ; 67,2% des patients étaient des hommes. Les patients asymptomatiques représentaient 31,1%. Les symptômes les plus courants à l'admission étaient la toux (60,8%) suivi de la fièvre (47,6%). Le plus grand nombre de cas a été enregistré à Bamako. CONCLUSION: L'infection par le SARS-CoV-2 des 1 030 premiers cas au Mali a été marquée par la prédominance de la toux et de la fièvre.

[Clinical and epidemiological characteristic of COVID-19 deaths in Mali]. / Caracteristiques clinique et epidemiologique des deces COVID-19 au Mali.

INTRODUCTION: Mali recorded its first COVID-19's death related case on March 26, 2020. The aim of this study was to evaluate the comorbidity of COVID-19's death related cases in the Malian context. METHOD: A cross-sectional study was conducted between March 25 and October 11, 2020. Community death information was analyzed from the patient descriptive list, and from the hospitalization registry of the treatment sites. RESULT: Of the 3,286 COVID-19 confirmed cases, 132 died making a lethality rate of 4.00% (132/3286). Men were the most represented with 75.76% (100/132). The mean age was 63.77 ± 15.25 years. The mean time of hospital stay was 4.50 days ± 6.35. Diabetes and cardiovascular disease remain the most frequent comorbidities with death patients with 20.45% and 17.42%, respectively. CONCLUSION: The results of this study allow to draw map of patients who died from COVID-19 as well as provide information on the comorbidities for better management of hospitalized patients.

INTRODUCTION: Le Mali a enregistré son premier cas de décès lié à la COVID-19, le 26 mars 2020.Le but de cette étude est d'étudier la comorbidité des cas de décès de COVID-19 dans le contexte malien. MÉTHODE: Il s'agissait d'une étude transversale allant de la période du 25 mars au 11 octobre 2020. Nous avons réalisé une analyse des informations de la liste descriptives des cas pour les décès communautaire et des registres d'hospitalisation des sites de prise en charge. RÉSULTAT: Sur les 3286 cas confirmés par la COVID-19, 132 malades en sont décédés soit une létalité de4,00%. Les hommes étaient les plus représentés avec 75,76 % (100/132). La moyenne d'âge était de 63,77 ans ± 15,25. La durée moyenne d'hospitalisation était de4,50 jours ± 6,35. Le diabète et l'HTA étaient les facteurs de comorbidité les plus fréquents rencontrés dans les cas de décès avec respectivement 20,45% et 17,42%. CONCLUSION: Cette étude a montré que les cas de décès liés au COVID-19 au Mali étaient observés chez les personnes âgées, diabétiques et hypertendues. Ces informations aideront à optimiser la prise en charge des malades hospitalisés.

[Spatio-temporal analysis of the incidence of morbidity and mortality from severe malaria in the Sélingué health district, Mali]. / Analyse spatio­temporelle de l'incidence de la morbidite et de la mortalite du paludisme grave dans le district sanitaire de Selingue, Mali.

AIMS/OBJECTIVES/ASSUMPTION: In Mali, malaria is the leading cause of death and consultations in health facilities. The objective of this study was to examine trends in morbidity and mortality among children aged 0 to 15 years and to establish accurate mapping of the distribution of cases in health areas of the Sélingué health district. MATERIALS AND METHOD: A retrospective analysis of hospital records at the Sélingué district reference health center from 2010 to 2013 was conducted. Trend Chi2 and logistic regression were used, respectively, to compare changes in trends between health areas and to identify risk factors associated with malaria mortality. RESULTS: Among the 1282 cases of malaria, the incidence of severe malaria gradually decreased from 96.75 ‰ (671 cases) in 2010 to 34.23 ‰ (291 cases) in 2011, 19.76 ‰ (168 cases) in 2012 and 19.43 ‰ (152 cases) in 2013. From 2010 to 2013, there was an average monthly variation in October of 26, 6% cerebralmalaria and 23.3% malaria anemia by the month of July of the same year. Spatial variation of anemic forms of malaria between health areas (p < 0.001) was observed from 2010 to 2013. From 2012 to 2013, there was an overall decrease in the frequency of hospitalizations, incidence and death rate for severe malaria. In multivariate analysis, in the final model, malaria lethality was associated with the duration of hospitalization for more than three days (OR = 0.124); the year of hospitalization from 2010 to 2012 (OR = 0.813); the absence of blood transfusion of the patient (OR = 0.282); at the age of the patient in children under one year (OR = 0.356) and at the emergency anti-malarial treatment instituted with artemether (OR = 3.006) adjusting for the form of malaria. On the other hand, malaria lethality was not related to the form of malaria (p = 0.072), sex (p = 0.390), residence (p = 0.308), prior treatment before hospitalization (p = 0.949). at fever in children (p = 0.153) adjusting for other variables in the model. CONCLUSION: Hospital case fatality remains high with a drop in the incidence of morbidity and mortality; a monthly variation in morbidity and mortality with two peaks, July - August and October-November and the emergency treatment instituted with artemether, the length of hospital stay could be identified as associated factors.

BUT/OBJECTIFS/HYPOTHÈSE: Au Mali, le paludisme est la principale cause de décès et de consultations dans les formations sanitaires. L'objectif de cette étude était de déterminer l'incidence de la morbidité et de la mortalité chez les enfants de 0 à 15 ans et d'établir une cartographie précise de la répartition des cas dans les aires de santé du district sanitaire de Sélingué. MATÉRIELS, MÉTHODE: Une analyse rétrospective des dossiers d'hospitalisation des enfants de 0 à 15 ans au niveau du centre de santé de référence du district de Sélingué de 2010 à 2013 a été réalisée. Le test de Chi2 de tendance et la régression logistique ont été utilisés respectivement pour comparer les variations de l'incidence entre les aires de santé et identifier les facteurs de risque associés à la mortalité palustre. RÉSULTATS: Parmi les 1282 cas de paludisme, l 'incidence du paludisme grave a diminué progressivement de 96,75‰ (671 cas) en 2010 à 34,23 ‰ (291 cas) en 2011, 19,76‰ (168 cas) en 2012 et 19,43‰ (152 cas) en 2013 (Chi2 de tendance p < 0,001). La létalité palustre a été de 15,13%, et n'a pas significativement varié, avec 13,31 % en 2010 et 14,05 % en 2013. De 2010 à 2013, on notait une variation mensuelle moyenne en octobre de 26,6% neuro paludisme et 23,3% de paludisme anémique vers le mois de juillet de la même année. Une variation spatiale des formes anémiques du paludisme entre les aires de santé (p < 0,001) a été observée de 2010 à 2013. De 2012 à 2013, il a été observé une baisse globale de la fréquence des hospitalisations, de l'incidence et du taux de décès pour le paludisme grave. En analyse multivariée, dans le modèle final, la létalité palustre était associée à la durée de l'hospitalisation de plus de trois jours (OR = 0,124) ; à l'année d'hospitalisation de 2010 à 2012 (OR = 0,813) ; à l'absence de transfusion sanguine du patient (OR = 0,282) ; à l'âge du patient chez les moins d'un an (OR = 0,356) et au traitement d'urgence anti paludique institué avec l'artemether (OR = 3,006) en ajustant pour la forme du paludisme. En revanche la létalité palustre n'était pas liée à la forme du paludisme (p = 0,072), au sexe (p = 0,390), à la résidence (p = 0,308), au traitement antérieur avant l'hospitalisation (p = 0,949), à la fièvre chez l'enfant (p = 0,153) en ajustant sur les autres variables dans le modèle. CONCLUSION: La létalité palustre hospitalière reste élevée avec une baisse des incidences de la morbidité et de la mortalité ; une variation mensuelle de la morbidité et de la mortalité avec deux pics, juillet - août et octobre-novembre et le traitement d'urgence institué avec l'artemether, la durée d'hospitalisation ont pu être identifiés comme des facteurs associés.

Performance of IRS on malaria prevalence and incidence using pirimiphos-methyl in the context of pyrethroid resistance in Koulikoro region, Mali.

BACKGROUND: Koulikoro Health District is one of three districts of Mali where the indoor residual spray (IRS) has been implemented from 2008 to 2016. With widespread of resistance to pyrethroid, IRS was shifted from pyrethroid to pirimiphos-methyl from 2014 to 2016. The objective of this study was to assess the added value of IRS to LLINs on the prevalence of parasitaemia and malaria incidence among children under 10 years old. METHODS: A comparative study was carried out to assess the effects of pirimiphos-methyl based IRS on malaria prevalence and incidence among children from 6 months to 10 years old in selected pyrethroid resistance villages of two health districts in Mali: one where IRS was implemented in combination with LLINs (intervention area) and one with LLINs-only (control area). Two cross-sectional surveys were carried out at the beginning (June) and end of the rainy season (October) to assess seasonal changes in malaria parasitaemia by microscopy. A passive detection case (PCD) was set-up in each study village for 9 months to estimate the incidence of malaria using RDT. RESULTS: There was an increase of 220% in malaria prevalence from June to October in the control area (14% to 42%) versus only 53% in the IRS area (9.2% to 13.2%). Thus, the proportional rise in malaria prevalence from the dry to the rainy season in 2016 was 4-times greater in the control area compared to the IRS area. The overall malaria incidence rate was 2.7 per 100 person-months in the IRS area compared with 6.8 per 100 person-month in the control areas. The Log-rank test of Kaplan-Meier survival analysis showed that children living in IRS area remain much longer free from malaria (Hazard ratio (HR) = 0.45, CI 95% 0.37-0.54) than children of the control area (P < 0.0001). CONCLUSIONS: IRS using pirimiphos-methyl has been successful in reducing substantially both the prevalence and the incidence of malaria in children under 10 years old in the area of pyrethroid resistance of Koulikoro, Mali. Pirimiphos-methyl is a better alternative than pyrethroids for IRS in areas with widespread of pyrethroid resistance.

Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali.

Intermittent preventive treatment in pregnancy (IPTp) with 3 or more doses of sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organization to prevent malaria in pregnant women living in high-risk areas. According to the 2015 malaria indicator survey in Mali, malaria prevalence is 34.6%. The high risk of malaria among pregnant women and children led the Malian government to provide free SP during antenatal clinics visits. The Malian National Program of Malaria Control recommends at least 3 doses during pregnancy. The proportion of pregnant women taking 3 or more doses of IPTp-SP (IPTp 3+) still remains low. In Mali, only 36.7% of pregnant women with a live birth in the past 2 yr received IPTp 3+. To investigate the factors associated with this low coverage, we carried out a secondary data analysis using the database of the Mali 2015 Malaria Indicator Survey. Multiple logistic regression was used to analyze these factors among 2,382 interviewed women. Taking less than 3 doses was higher among women below 20 yr (adjusted odds ratio [AOR] = 1.43, 95% confidence interval [CI, 1.03; 1.98]); however, media accessibility (listening to radio) (AOR = 0.71, 95% CI [0.53-0.95]) and residing in Segou (AOR = 0.56, 95% CI [0.35-0.90]) seem to favor the opposite after adjusting the potential confusion. Residence, educational level, and wealth index were not statistically associated with taking 3 doses of IPTp-SP. This study identifies that women less than 20 yr of age were significantly associated with taking lower than 3 doses of IPTp-SP.

Discrepant prevalence and incidence of Leishmania infection between two neighboring villages in Central Mali based on Leishmanin skin test surveys.

UNLABELLED: Apart from a single report, the last publication of cutaneous leishmaniasis (CL) in Mali dates back more than 20 years. The absence of information on the current status of CL in Mali led us to conduct a cohort study in Kemena and Sougoula, two villages in Central Mali from which cases of CL have been recently diagnosed by Mali's reference dermatology center in Bamako. In May 2006, we determined the baseline prevalence of Leishmania infection in the two villages using the leishmanin skin test (LST). LST-negative individuals were then re-tested over two consecutive years to estimate the annual incidence of Leishmania infection. The prevalence of Leishmania infection was significantly higher in Kemena than in Sougoula (45.4% vs. 19.9%; OR: 3.36, CI: 2.66-4.18). The annual incidence of Leishmania infection was also significantly higher in Kemena (18.5% and 17% for 2007 and 2008, respectively) than in Sougoula (5.7% for both years). These data demonstrate that the risk of Leishmania infection was stable in both villages and confirm the initial observation of a significantly higher risk of infection in Kemena (OR: 3.78; CI: 2.45-6.18 in 2007; and OR: 3.36; CI: 1.95-5.8 in 2008; P<0.005). The absence of spatial clustering of LST-positive individuals in both villages indicated that transmission may be occurring anywhere within the villages. Although Kemena and Sougoula are only 5 km apart and share epidemiologic characteristics such as stable transmission and random distribution of LST-positive individuals, they differ markedly in the prevalence and annual incidence of Leishmania infection. Here we establish ongoing transmission of Leishmania in Kemena and Sougoula, Central Mali, and are currently investigating the underlying factors that may be responsible for the discrepant infection rates we observed between them. TRIAL REGISTRATION: ClinicalTrials.gov NCT00344084.